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ABSTRACT 
 
BACKGROUND. The steroid triamcinolone acetonide (TA) is a potent anti-angiogenesis drug 
used to treat retinal vascular diseases that include diabetic retinopathy, vascular occlusions and 
choroidal neovascularization. 
PURPOSE. To quantify the effects of TA on branching morphology within the angiogenic 
microvascular tree of the chorioallantoic membrane (CAM) of quail embryos. 
METHODS. Increasing concentrations of TA (0–16 ng/ml) were applied topically on embryonic 
day 7 (E7) to the chorioallantoic membrane (CAM) of quail embryos cultured in Petri dishes, and 
incubated for an additional 24 or 48 hours until fixation. Binary (black/white) microscopic images 
of arterial end points were quantified by VESGEN software (for Generational Analysis of Vessel 
Branching) to obtain major vascular parameters that include vessel diameter (Dv), fractal 
dimension (Df), tortuosity (Tv) and densities of vessel area, length, number and branch point (Av, 
Lv, Nv and Brv). For assessment of specific changes in vascular morphology induced by TA, the 
VESGEN software automatically segmented the vascular tree into branching generations 
(G1…G10) according to changes in vessel diameter and branching.  
RESULTS. Vessel density decreased significantly up to 34% as the function of increasing 
concentration of TA according to Av, Lv, Brv, Nv and Df. TA selectively inhibited the growth of 
new, small vessels, because Lv decreased from 13.14 ± 0.61 cm/cm2 for controls to 8.012 ± 
0.82 cm/cm2 at 16 ng TA/ml in smaller branching generations (G7-G10), and for Nv from 473.83  ± 
29.85 cm-2 to 302.32  ± 33.09  cm-2. In contrast, vessel diameter (Dv) decreased throughout the 
vascular tree (G1-G10). 
 
Key Words: triamcinolone acetonide; angiogenesis; retinal neovascularization; fractal; 
chorioallantoic membrane; CAM; quail; avian.
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INTRODUCTION 
The steroid triamcinolone acetonide (TA) is a potent anti-inflammatory and anti-
angiogenic drug used for treatment of macular edema secondary to retinal vascular diseases 
including diabetic retinopathy and retinal vascular occlusions, as well as neovascularization 
including choroidal neovascularization (CNV) and retinal neovascularization in inflammatory 
diseases. It is believed that corticosteroids decrease levels of retinal thickening and improve 
macular edema by several mechanisms. TA decreases inflammatory mediators that include 
tumor necrosis factor, interleukin 5, interleukin 6, interleukin 8, prostaglandins and interferon-
gamma.1-3 TA modulates cellular calcium levels by interacting with both voltage-dependent 
calcium channels and calmodulin.4, 5 These activities may promote more effective fluid 
resorption, resulting in decreased macular edema. Corticosteroids also decrease levels of the 
potent permeability factor, vascular endothelial growth factor (VEGF).6, 7 Finally, TA improves 
the integrity of the blood-retinal barrier.8 Regardless of the mechanisms of activity, TA has been 
documented to significantly improve vision and decrease retinal edema.9-12   
Although the clinical effect of TA in these diseases is established, the effect of TA on 
vascular morphology is not well understood. Improved understanding of how TA affects 
angiogenesis and vascular morphology would be helpful for therapeutic optimization. For this 
study, site-specific changes within the vascular tree induced by TA were quantified using an in 
vivo model of angiogenesis.  
For evaluation of the effects of TA on the angiogenic vascular tree, the quail 
chorioallantoic membrane (CAM) is a highly useful model during mid-development, when the 
rate of CAM angiogenesis is at a maximum.13-17 As described previously, the complex spatial 
patterns of the branching vascular tree and the associated capillary network can be easily 
visualized by light and fluorescence/confocal microscopy.13-17 Using fractal analysis, this 
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vascular pattern can be precisely analyzed. Fractal analysis is a recent non-Euclidean 
mathematical innovation18 that quantifies the space-filling patterns of complex objects. Fractal 
geometry is common in nature and includes botanical and vascular trees, snowflakes, coastline 
topography, and even the spatiotemporal scaling of vascular-based physiological metabolism.19, 
20 As a fractional, non-integral number that increases according to the increasing density of a 
space-filling pattern, the fractal dimension (Df) is statistically sensitive to small, early-stage 
changes in the vascular tree.13-15, 17, 21 A fractal object typically reaches its greatest space-filling 
capacity using self-similarity, the geometric property by which a pattern such as vascular 
bifurcational branching is repeated iteratively at continuously decreasing length scales. 
The computer program VESGEN (abbreviated from Generational Analysis of Vessel 
Branching) was developed by NASA as a fully automated, user-interactive program that 
quantifies major vascular branching parameters using a single, user-provided image of 2D 
vascular pattern. The fractal-based VESGEN analysis segments vessels within vascular trees 
into branching generations (G1, G2, … Gx) according to changes in vessel diameter and 
branching. Site-specific changes within the vascular tree induced by angiogenic cytokines or 
other molecular regulators such as TA can then quantified.14-16 Thus, the purpose of this study 
was to evaluate the effects of the TA on branching morphology within the microvascular tree of 
the quail CAM model using fractal-based VESGEN analysis. 
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MATERIALS AND METHODS 
 
 Embryonic culture, assay, mounting, imaging, and fractal/VESGEN branching analysis used 
in this study have been described previously,14-17 and are summarized below. 
Culture, Assay and Mounting 
 Fertilized eggs of Japanese quail (Coturnix coturnix japonica, Boyd's Bird Co., Pullman, WA) 
were incubated at 37.6 ± 0.2 °C under ambient atmosphere, cracked at embryonic day three (E3, 
following incubation of eggs for 56 hours) and cultured further in 6-well petri dishes (cross-sectional 
area = 10 cm2). Quail egg culture and experimental protocols were in accord with NIH guidelines 
and approved by the Chief Veterinarian Officer of NASA (Ames Research Center). At E7 (following 
incubation for an additional 96 h), prewarmed PBS solution containing TA (0.5 ml at 0-16 ng/ml) 
was applied dropwise to the surface of each CAM. Sterile-filtered stock solutions of TA (Sigma, T-
6501) were prepared at 10 mg/ml in 100% ethanol. Additional concentrations of TA were tested to 
determine the range of dose effectiveness. The total amount of the molecular regulator, rather than 
its concentration, is the governing parameter because solutions are quickly absorbed into CAM 
tissue. Quantities of TA are therefore reported as 0-8 ng/CAM. Following treatment with TA and 
further incubation for 24 or 48 hours, the embryos (with CAMs) were fixed in 4% 
paraformaldehyde/2% glutaraldehyde/PBS for several days prior to dissection and mounting for 
microscopic analysis.13 
Imaging 
 Aldehyde fixation of the CAM results in high contrast of the arterial tree due to retention of 
erythrocytes (or red blood cells, RBC) within arteries, but low contrast of the venous tree resulting 
from evacuation of RBC from veins during dissection (Fig. 1).13 Digital images (1392 × 1040 pixels) 
of (terminal) arterial end-point vessels from the middle region of the CAM were acquired in 
McKay et al Steroid Inhibition of Vessel Density and Diameter Page 6 
 
 6 
grayscale (0-255 intensity) at total 12.5X magnification and resolution of 7.32 µm/pixel (Leica 
DM4000B microscope attached to Retiga EXi CCD camera, Qimaging, by Image Pro Plus 
software). Previous studies showed that the CAM arterial end-point regions analyzed by us are 
representative of changes induced by topical application of angiogenesis regulators throughout the 
CAM arterial trees,13 and there is no significant increase in vascular density at a total magnification 
of 20X in comparison to 12.5X. Grayscale images were converted into binary (black/white) images 
of vascular morphology (Fig. 1) by semi-automatic computer processing using Adobe Photoshop 
7.0 and NIH ImageJ software (http://rsb.info.nih.gov/ij/). The accuracy of vascular image 
binarization was confirmed by a second independent, experienced operator. 
Vascular Quantification  
Statistical Sampling 
 Thirty-nine representative CAM specimens were quantified from three independent 
experiments, including at least three controls from each experiment (a total of eleven controls), and 
seven specimens for each of the four concentrations of TA. Additional specimens and experiments 
served as qualitative confirmation of the quantified results. Variation was assessed by calculating 
the standard error (S.E.). P-values were obtained for the four treatment groups (1-8 ng TA/CAM) 
compared to control (0 ng TA/CAM) by two-tailed, heteroscedastic Student’s t-test. 
Analysis by VESGEN 
 The NASA Glenn computer code VESGEN (Fig. 2) was used to measure parameters of 
vascular morphology that include vessel length density (Lv), vessel area density (Av), vessel branch 
point density (Brv), vessel number density (Nv), vessel tortuosity (Tv) and vessel diameter (Dv) for 
each branching generation G1 through G10. For example, Dv1-2 denotes Dv with respect to branching 
generations G1-G2. By VESGEN analysis, only one image was found to contain 11 branching 
generations (i.e., a few vessels of G11), which were therefore merged into image results for G7-10  
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(G≥7). Lv, Av, Nv and Brv were expressed as density functions by normalization to the area of the 
image containing the major arterial tree extracted as region of interest (ROI) or (2) the entire image 
(Fig. 2). Vessel diameter was calculated as Dv = Av/Lv. A trimmed skeleton was used to obtain 
accurate measurements for Lv in specific branching generations such as Lv1.16 Tortuosity (Tv) was 
estimated by the ratio of the length of a trimmed vessel (Lv) determined by VESGEN to the shortest 
distance  between the vessel endpoints.  
 Vessel branching generations (G1-GX) are determined by VESGEN according to relative 
decreases in vessel diameter, as first established for branching vascular trees in the dog and pig 
heart and lung.22-24  Blood flow is conserved at a symmetric vessel bifurcation when the diameter of 
a symmetric offspring vessel decreases to 71% (1/square root of 2) of the parent vessel diameter, 
and therefore the decrease of vessel diameter to 71% was used as the primary determinant of a 
new branching generation. As can be seen in biological branching trees (Fig. 2), however, the 
branching of relatively symmetric offspring vessels is not perfectly symmetric, and the diameters of 
very few offspring vessels are of the 71% ideal value. In addition, vessels tend to taper. To 
accommodate a range of vessel diameters within a branching generation, VESGEN therefore 
contains a 15% default tolerance factor that is user-adjustable. For the TA study, the tolerance 
factor was left at ± 15%. For a very small number of vessel segments (only 5 vessel segments out 
of 39 total images), the automatic segmentation by VESGEN was incorrect according to the 
established criteria of generational classification based on vessel diameter and branching. The 
user-interactive features of VESGEN were therefore used to override and correct these few 
inaccuracies. A further consideration is that the most frequent branching event in a vascular tree is 
the asymmetric offshoot branching of a much smaller vessel from a larger vessel, presumably due 
to space-filling requirements of vascular branching (Fig. 2). It is important to note that although the 
branching pattern of each vascular tree in a CAM or a human retina is unique, the space-filling 
properties of the vascular trees are remarkably uniform.13, 21  
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 VESGEN now functions as a fully automated, Java-based software operating as a plug-in to 
NIH ImageJ. A binary vascular image is the single input required by VESGEN to quantify vascular 
trees, networks or tree-network composites of highly 2D tissues such as the avian CAM, human 
retina and rodent retina. VESGEN will be publicly available in the near future, and its full capabilities 
are being described elsewhere.  
Fractal Analysis 
To support fractal analysis by the box-counting algorithm,13 each binary image was 
rescaled slightly to 1370 x 1024. A left- and right-most square image of 1024 x 1024 was 
extracted from each binary image and skeletonized (i.e., linearized, Fig. 1) using the NIH 
ImageJ skeletonizing algorithm. The fractal dimension (Df) was calculated for binary and 
skeletonized images by implementation of box-counting at a power of 2 using ImageJ.13  Values 
of Df for the left and right 1024 x 1024 images were averaged to obtain an overall Df for each 
original image. The fractal box-counting algorithm has since been incorporated into VESGEN to 
confirm the TA fractal results and for use in future studies. We consider VESGEN to be a fractal-
based analysis of vascular trees due to the complex, non-Euclidean space-filling geometry of 
the vascular branching structures, and VESGEN assignment of vascular parameters to specific, 
self-similar generations of vascular branching.  
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RESULTS 
 Topical application of TA significantly inhibited ongoing angiogenesis in the quail CAM after 
24 hours by two major morphological mechanisms: (1) vascular density was inhibited by a targeted 
decrease in the number of small blood vessels, and (2) decreased vessel diameter throughout the 
vascular tree. Vascular density decreased as a function of increasing concentration of TA (Fig. 3) by 
several confirming measures of the entire vascular field in binary and skeletonized images. 
Skeletonized images are direct representations of vessel density that illustrate the extensive space-
filling properties and overall vessel connectivity of a branching vascular tree. Visual inspection of 
vascular pattern further confirms these results (Figs. 1, 4). By microscopic observation, decreased 
vascular density and alterations in vessel diameter induced by TA at 4-8 ng/CAM persisted after 48 
hours (results not shown). 
 Within skeletonized images, Lv and Brv decreased up to 23% and 34%, respectively (Fig. 3). 
Df, Lv and Brv decreased from 1.406 ± 0.004, 25.7 ± 0.6 (cm/cm2), and 454 ± 28 (cm-2) in controls to 
1.355 ± 0.008, 19.5 ± 0.9 (cm/cm2), and 301 ± 27 (cm-2) in specimens treated at the maximum 
concentration of 8 ng TA/CAM (p values = 3xE-4, 1xE-4 and 0.001, respectively). In binary images, 
Df and Av decreased from 1.669 ± 0.006 and 0.14 ± 0.00 (cm2/cm2) in controls to 1.623 ± 0.009 and 
0.11 ± 0.005 (cm2/cm2) at 8 ng TA/CAM (p = 0.0015 and 6xE-4). Absolute differences of Df in binary 
and skeletonized images may appear small. However, as a non-Euclidean, 'fractional' measure of 
space-filling patterns, Df is restricted in 2D, black/white images to fractional values between 1 and 2. 
Df is a sensitive, statistically significant, reproducible measure of space-filling vascular density that 
ranges from approximately 1.34 to 1.55 in skeletonized images and 1.61 to 1.75 in binary images.13-
15, 17, 21  
 Decreases in vascular density as measured by Df and Av in binary images can result from 
several morphological changes that include decreased vessel length and number of vessels, and/or 
decreased vessel diameter (see Fig. 1B, E). Quantitative analysis by VESGEN confirmed visual 
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observations that the morphological mechanisms of decreased vascular density induced by TA 
include: (1) decreased number densities restricted to smaller vessels, and (2) overall thinning of 
vessel diameter. Vessel tortuosity as measured by Tv was unaffected, varying typically between 
1.04 and 1.17 within a specimen. By Nv and Lv (Fig. 5), vessel density decreased significantly for 
the smallest vessels of G7-G10, but not for large and medium-sized vessels of G1-G2, G3-G4 and G5-
G6. Nv7-10 decreased significantly from 474 ± 30 cm-2 in controls to 302 ± 33 cm-2 at 8 ng TA/CAM (p 
= 0.0017), whereas Nv1-2, Nv3-4 and Nv5-6 remained relatively constant (see Fig. 5; p = 0.69, 0.53 and 
0.61, respectively). For example, Nv1-2 was 5.04 ± 0.32 cm-2 in controls compared to 5.15 ± 0.05 cm-
2 at 8 ng TA/CAM. Small but consistent decreases in vessel diameter (Dv) were induced by TA 
throughout the vascular tree (Fig. 6). Dv7-10 decreased from 28.1 ± 1.0 µm in controls to 25.5 ± 0.4 
µm at 8 ng TA/CAM (p = 0.03), Dv5-6 from 61.1 ± 3.1 µm to 53.0 ± 3.1 µm (p = 0.08), Dv3-4 from 118.1 
± 6.0 µm to 101.6 ± 5.8 µm (p = 0.07), and Dv1-2 from 228.4 ± 12.1 µm to 199.0 ± 11.2 µm (p = 
0.09). 
 A statistical study of the effects of vessel generational branching on our results confirmed 
the value and validity of site-specific VESGEN analysis. The binning (i.e., lumping or merging) of 
G1-G10 output parameters demonstrated increasingly strong statistical confidence resulting from 
increasingly fine binning of the generational data. For example, measurements of Dv using a two-
fold binning of generations for controls and 8 ng TA/CAM into larger vessels of Dv1-6 and smaller 
vessels of Dv7-10 (this group identical to results cited above) yielded a p-value of relatively 
insignificant difference for the larger vessels (p = 0.15). Similarly, for a three-fold binning of 
generations into Dv1-3, Dv4-6, and Dv7-10, p-values for the two groups of larger vessels were also 
inconclusive (p = 0.25 and p = 0.15, respectively). As described above, a finer four-fold binning of 
Dv1-2, Dv3-4, Dv5-6, and Dv7-10 showed considerably higher levels of statistical significance for trends (p 
≤ 0.10) and confidence intervals (p ≤ 0.05). Nonetheless, some binning of generational results as 
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performed for this study improves and smooths the data due to increased statistical sampling14, 17 
and provides greater clarity in presentation of results. 
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DISCUSSION 
 Topical treatment with the corticosteroid triamcinolone acetonide (TA) resulted in multimodal 
changes to the vascular tree in the quail CAM, as quantified by VESGEN analysis. The 
angiogenesis of small blood vessels was selectively inhibited by TA, although vessel diameter 
decreased throughout the branching tree. Other critical aspects of vessel morphology remained 
normal following treatment by TA. For example, the density and number of larger vessels were 
unaffected, the vascular tree appeared to taper smoothly, and vessel tortuosity remained normal. It 
is not surprising that TA, as a potent angiogenesis inhibitor, selectively decreased the density of 
only small, new blood vessels within the vascular tree.14 It is possible that TA decreased overall 
vessel diameter by inhibiting VEGF activity,6,7 because VEGF stimulates increases in vessel 
diameter (particularly of larger vessels) as well as in vessel density.17 
 In this study, TA was applied topically to the quail chorioallantoic membrane during mid-
embryonic development when angiogenesis is occurring at its maximum rate, and angiogenic 
cytokines and regulators can be applied easily and uniformly in solution.13-17 The transparent CAM 
membrane develops rapidly, is highly vascularized, and is essentially 2D. Complex spatial patterns 
of the branching vascular tree and associated capillary network are easily visualized by light and 
fluorescence/confocal microscopy, and quantified by fractal-based VESGEN analysis. As a 
relatively convenient experimental model, the angiogenic CAM exhibits some useful morphological 
and functional similarities to angiogenic diseases of the quasi-2D retinal vascular tree. For example, 
region-based fractal methods developed in the CAM were successfully extended to the 
quantification of progression in diabetic vascular disease using clinical images of the human 
retina.21 
 We are using the computer software VESGEN (for Generational Analysis of Vessel 
Branching) to quantify major vessel parameters of blood and lymphatic vascular remodeling. 
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Output parameters of VESGEN include vessel diameter, tortuosity, fractal dimension, and 
densities of vessel number, branch point, length and area. Most parameters can be obtained by 
the user for the overall vascular image, the major vascular tree, and for individual or merged 
branching generations. Vascular trees are decomposed into branching generations so that 
cytokine- or therapeutic-regulated modifications can be quantified according to site-specific 
vessel location. For this study on TA, we chose to analyze generational branching within the 
major vascular tree. Focusing on branching relationships within a single tree can support 
precise conclusions about regulator-induced changes in vessel branching relationships. This is 
the first technical report of results generated by the fully mature, newly automated VESGEN 
software (version 1.0) that now analyzes 2D vascular trees, networks and tree-network 
composites for a number of experimental and clinical tissue applications in angiogenesis and 
lymphangiogenesis, including the avian CAM and yolksac, the human retina, rodent retina, and 
developing coronary vessels in the embryonic heart.  
 As demonstrated by VESGEN analysis, it now appears that perturbation of rapid, 
ongoing angiogenesis during the middle stages of CAM development by TA occurs primarily by 
the selective inhibition or stimulation of new, small blood vessels. As a generalized result for the 
CAM model, this conclusion appears important although not particularly surprising, because the 
molecular and cellular characteristics of angiogenic vascular tissues differ from those of more 
mature, stable vascular tissues.25, 26 Angiogenic perturbants quantified to date in this fractal-
based CAM model include the inhibitors TA, transforming growth factor β-1 (TGF-β1)14 and 
angiostatin,13 and stimulators basic fibroblast growth factor (bFGF)15 and vascular endothelial 
growth factor-165 (VEGF165).17 Additional regulator-specific effects on vascular morphology such 
as overall vessel thinning by TA or thickening of larger blood vessels by VEGF165 have also 
been quantified. As for TA, morphological response of the vascular tree to VEGF165 measured 
by VESGEN was multimodal. Increased vessel density and increased vessel diameter reached 
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maximal frequencies at lower and higher VEGF concentrations, respectively. The study of TGF-
β1 in particular considered tissue growth (rescaling) of the entire CAM vascular tree. Each 
molecular perturbant of angiogenesis has therefore elicited a unique 'fingerprint' response that is 
spatiotemporally distinct and quantifiable, despite the apparent generality of inhibition and 
stimulation of angiogenesis in the CAM at the level of new, small vessels within the growing 
vascular tree.  
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FIGURE IMAGES AND LEGENDS 
 
 
Fig. 1. Image analysis. 
Representative images of arterial end-point regions of CAM specimens treated with PBS control 
vehicle (A) or with corticosteroid triamcinolone acetonide (TA, D) were acquired by brightfield 
microscopy. Aldehyde fixation of the CAM results in retention of RBCs within arterial vessels 
(arrows) and extraction of large amounts of blood from venous vessels (arrowheads). Arterial 
trees are thereby conveniently separated from overlapping venous trees to support the semi-
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automatic processing of grayscale images into (B, E) binary (black/white) vascular patterns. 
Binary images and (C, F) corresponding skeletonized images clearly reveal strong inhibition of 
vessel density by TA. Measurements of decreased vessel density at 8 ng TA/CAM (E, F) 
relative to control (B, C) include: (E) vessel area density (Av) = 0.122 (cm2/cm2) and fractal 
dimension (Df ) = 1.656, compared to (B) Av = 0.152 (cm2/cm2) and Df = 1.683; (F) vessel length 
density (Lv) = 20 (cm/cm2), vessel branch-point density (Brv) = 325 (cm-2) and Df = 1.360 
compared to (C) Lv = 26 (cm/cm2), Brv = 443 (cm-2) and Df = 1.410. 
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Fig. 2. Assignment of vessels to branching generations G1-G10 by VESGEN. 
The VESGEN output image of a CAM control specimen illustrates the classification of vessels 
into successively smaller branching generations. Ten branching generations (G1-G10) of vascular 
branching were measured by VESGEN for the arterial end-point region of this control CAM 
specimen. Vessel branching generations are determined by (1) decrease in vessel diameter and 
(2) vessel bifurcations that are approximately symmetric (i.e., when diameters of offspring 
vessels branching from a parent vessel are approximately equal). The major arterial tree and its 
corresponding region of interest (ROI, in black) are also identified by VESGEN. The edge of the 
ROI lies midway between the end points of the major arterial tree and neighboring arteries. In 
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regions where vessels of the arterial tree extend beyond the edge of the image, the ROI is 
defined simply by the edge of the image. As seen above, the most frequent branching event 
within the vascular tree is asymmetric branching, or branching of a small offshoot vessel from a 
much larger vessel. In this ROI, 35 symmetric branch points and 209 asymmetric branch points 
were measured by VESGEN. 
 
 
Fig. 3. Vessel density decreases as the function of increasing concentration of 
TA. 
As a measure of the space-filling capacity of a vascular pattern, the fractal dimension (Df) 
decreased significantly with increasing TA concentration in (A) binary and (B) skeletonized 
images throughout the entire vascular field, as illustrated in Fig. 1. Vessel density also 
decreased according to other measures of vessel density that include (C) vessel length density 
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(Lv) and (D) vessel branch point density (Brv). Data are plotted as mean ± S.E. P-values ≤ 0.05 
and ≤ 0.01 are indicated by * and **, respectively. 
 
Fig. 4. TA selectively decreases the number of smaller vessels and decreases 
vessel diameter throughout the vascular tree. 
(A-C) Each representative image displays the major arterial tree with its ROI (in black) as 
determined by VESGEN, for which vessel diameter (Dv) and the density of key vascular 
parameters that  include vessel number density (Nv), vessel branch point density (Brv), vessel 
length density (Lv), and vessel area density (Av), were measured. Parameters were specified for 
branching generations G1-G10 (see colorized legend) and denoted Dv1, Av1, Lv1, Nv1, etc. Relative 
to controls (A), VESGEN results for Av, Lv, Nv and Brv in TA-treated specimens (B-C) show that 
vessel density decreased only in the smallest branching generations G7-G10 (Fig. 5). However, 
Dv decreased throughout vascular tree (Fig. 6). B above is the VESGEN output image of the 
input binary image Fig. 1E. 
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Fig. 5. TA selectively inhibits the angiogenesis of small blood vessels. 
Relative to controls, vessel density estimated by vessel number density (Nv) and vessel length 
density (Lv) decreased only in the smallest branching generations G7-G10 for higher 
concentrations of TA. For clarity, results for various classes of vessels lumped together as G1-2, 
G3-4, G5-6 and G≥7 (G7-10). See Figs. 1, 2 and 4 for qualitative confirmation of the quantitative 
results. Data are plotted as mean ± S.E. P-values ≤ 0.05 and ≤ 0.01 are indicated by * and **. 
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Fig. 6. TA decreases vessel diameter throughout the vascular tree. 
Vessel diameter (Dv) decreased in all vessel branching generations (G1-G10) with increasing 
concentration of TA, relative to controls. As for Fig. 5, results were lumped together as G1-2, G3-4, 
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G5-6 and G≥7 (G7-10). For qualitative confirmation of quantitative results, see Figs. 1 and 4. Data 
are plotted as mean ± S.E. P-values ≤ 0.05 and ≤ 0.01 are indicated by * and **. 
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